资讯
Bayesian Health Sepsis Monitor Wins Medicare Add-on Payment Approval
📌 概要
Bayesian Health宣布其获FDA许可的脓毒症AI持续监测设备获准纳入Medicare新技术附加支付（NTAP），自2026年10月1日起，医院对符合条件住院病例使用该设备可获得额外医保支付。公司称这是针对疑似前脓毒症预警的首个此类报销通道，有望加速AI临床监测工具的医院落地。
⚡ 关键要点
- ▸Bayesian Health脓毒症AI监测设备获批Medicare新技术附加支付
- ▸2026年10月1日起医院可对符合条件的住院病例获得额外支付
- ▸公司称其为疑似前脓毒症预警领域首个报销通道
Bayesian Health announced on September 2, 2026 that its FDA-cleared sepsis flagging device has been approved for a New Technology Add-on Payment, the Medicare mechanism that temporarily reimburses hospitals for using qualifying new technologies. Beginning October 1, 2026, hospitals using the continuous AI sepsis monitor can receive additional Medicare payment for eligible inpatient cases. The company described the approval as the first reimbursement pathway of its kind for pre-suspicion sepsis…